As of 2025-07-11, the Relative Valuation of Cytokinetics Inc (CYTK) is (112.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.59 USD, the upside of Cytokinetics Inc based on Relative Valuation is -408.0%.
The range of the Relative Valuation is (72.12) - (140.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 27.2x | 20.3x |
| Forward P/E multiples | 14.0x - 32.9x | 23.4x |
| Fair Price | (72.12) - (140.12) | (112.69) |
| Upside | -297.1% - -483.0% | -408.0% |
| Date | P/E |
| 2025-07-10 | -7.10 |
| 2025-07-09 | -7.11 |
| 2025-07-08 | -6.65 |
| 2025-07-07 | -6.48 |
| 2025-07-03 | -6.73 |
| 2025-07-02 | -6.67 |
| 2025-07-01 | -6.53 |
| 2025-06-30 | -6.41 |
| 2025-06-27 | -6.44 |
| 2025-06-26 | -6.58 |
| 2025-06-25 | -6.43 |
| 2025-06-24 | -6.48 |
| 2025-06-23 | -6.34 |
| 2025-06-20 | -6.30 |
| 2025-06-18 | -6.35 |
| 2025-06-17 | -6.32 |
| 2025-06-16 | -6.56 |
| 2025-06-13 | -6.67 |
| 2025-06-12 | -6.44 |
| 2025-06-11 | -6.43 |
| 2025-06-10 | -6.70 |
| 2025-06-09 | -6.43 |
| 2025-06-06 | -6.27 |
| 2025-06-05 | -6.23 |
| 2025-06-04 | -6.29 |
| 2025-06-03 | -6.21 |
| 2025-06-02 | -6.06 |
| 2025-05-30 | -6.02 |
| 2025-05-29 | -6.08 |
| 2025-05-28 | -5.88 |
| 2025-05-27 | -5.93 |
| 2025-05-23 | -5.93 |
| 2025-05-22 | -5.92 |
| 2025-05-21 | -6.08 |
| 2025-05-20 | -6.34 |
| 2025-05-19 | -5.97 |
| 2025-05-16 | -6.02 |
| 2025-05-15 | -5.79 |
| 2025-05-14 | -5.82 |
| 2025-05-13 | -5.94 |
| 2025-05-12 | -6.24 |
| 2025-05-09 | -6.15 |
| 2025-05-08 | -6.30 |
| 2025-05-07 | -6.41 |
| 2025-05-06 | -6.59 |
| 2025-05-05 | -7.12 |
| 2025-05-02 | -7.25 |
| 2025-05-01 | -8.33 |
| 2025-04-30 | -8.32 |
| 2025-04-29 | -8.01 |